CXCR-7 receptor promotes SDF-1α-induced migration of bone marrow mesenchymal stem cells in the transient cerebral ischemia/reperfusion rat hippocampus

Brain Research

Volumn 1575, Issue , 2014, Pages 78-86

  Wang, Yulan ^a   Fu, Wei ^a   Zhang, Shichun ^a   He, Xiaomei ^a   Liu, Zhi'an ^a   Gao, Diansuai ^a   Xu, Tiejun ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem; C X C chemokine receptor 7; Cell; Hippocampus; Ischemia reperfusion; Migration; Stromal cell derived factor 1

Indexed keywords

BROXURIDINE; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; GREEN FLUORESCENT PROTEIN; NEUTRALIZING ANTIBODY; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1ALPHA; CHEMOKINE RECEPTOR CXCR; CMKOR1 PROTEIN, RAT; CXCL12 PROTEIN, RAT; CXCR4 PROTEIN, RAT; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL OCCLUSION; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRAIN ISCHEMIA; CELL CULTURE; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; ENZYME MECHANISM; FLOW CYTOMETRY; FOUR VESSEL OCCLUSION; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LATERAL BRAIN VENTRICLE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL MOTION; HIPPOCAMPUS; MESENCHYMAL STROMA CELL; METABOLISM; SPRAGUE DAWLEY RAT; TRANSIENT ISCHEMIC ATTACK;

RATTUS;

ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL12; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR; RECEPTORS, CXCR4; REPERFUSION INJURY;

EID: 84925883701     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.05.035     Document Type: Article

References (46)

1. Andres, R.H., Choi, R., Steinberg, G.K., Guzman, R., 2008. Potential of adult neural stem cells in stroke therapy. Regen. Med. 3, 893-905.
2. Balabanian, K., Lagane, B., Infantino, S., Chow, K.Y., Harriague, J., Moepps, B., et al, 2005. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280, 35760-35766.
3. Bakondi, B., Shimada, I.S., Peterson, B.M., Spees, J.L., 2011. SDF-1α secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7. Stem Cells Dev. 20 (6), 1021-1029.
4. Begley, L.A., MacDonald, J.W., Day, M.L., Macoska, J.A., 2007. CXCL12 activates a robust transcriptional response in human prostate epithelial cells. J. Biol. Chem. 282, 26767-26774.
5. Burns, J.M., Summers, B.C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., et al, 2006. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201-2213.
6. Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., 2001. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005-1011.
7. Chen, X., Li, Y., Wang, L., Katakowski, M., Zhang, L., Chen, J., et al, 2002. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22, 275-279.
8. Cui, X., Chen, J., Zacharek, A., Li, Y., Roberts, C., Kapke, A, et al, 2007. Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke. Stem Cells 25, 2777-2785.
9. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al, 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8, 315-317.
10. Feng, Y., Broder, C.C., Kennedy, P.E., Berger, E.A., 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
11. Gillette, J.M., Larochelle, A., Dunbar, C.E., Lippincott-Schwartz, J., 2009. Intercellular transfer to signaling endosomes regulates an ex vivo bone marrow niche. Nat. Cell Biol. 11, 303-311.
12. Göttle, P., Kremer, D., Jander, S., Odemis, V., Engele, J., Hartung, H. P., et al, 2010. Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann. Neurol. 68, 915-924.
13. Hartmann, T., Grabovsky, V., Pasvolsky, R., Shulman, Z., Buss, E.C., Spiegel, A., et al, 2008. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J. Leukoc. Biol. 84, 1130-1140.
14. Hayakawa, J., Migita, M., Ueda, T., Fukazawa, R., Adachi, K., Ooue, Y., et al, 2009. Dextran sulfate and stromal cell derived factor-1 promote CXCR4 expression and improve bone marrow homing efficiency of infused hematopoietic stem cells. J. Nippon Med. Sch. 76, 198-208.
15. Hess, D.C., Borlongan, C.V., 2008. Stem cells and neurological diseases. Cell Prolif. 41, 94-114.
16. Hu, X., Wei, L., Taylor, T.M., Wei, J., Zhou, X., Wang, J.A., et al, 2011. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation. Am. J. Physiol. Cell Physiol. 301, C362-C372.
17. Janowski, M., 2009. Functional diversity of SDF-1 splicing variants. Cell. Adhes. Migr. 3, 243-249.
18. Ji, J.F., He, B.P., Dheen, S.T., Tay, S.S., 2004. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22, 415-427.
19. Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura, L., Allendorf, D.J., et al, 2004. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 35, 233-245.
20. Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Ishii, K., Kobune, M., et al, 2005. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol. Ther. 11, 96-104.
21. Kyriakou, C., Rabin, N., Pizzey, A., Nathwani, A., Yong, K., 2008. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 93, 1457-1465.
22. Li, Y., Chopp, M., 2009. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci. Lett. 456, 120-123.
23. Li, X., Ma, Q., Xu, Q., Liu, H., Lei, J., Duan, W., et al, 2012. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through noncanonical activation of Hedgehog pathway. Cancer Lett. 322, 169-176.
24. Liu, H., Xue, W., Ge, G., Luo, X., Li, Y., Xiang, H., et al, 2010. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Biochem. Biophys. Res. Commun. 401, 509-515.
25. Liu, H., Liu, S., Li, Y., Wang, X., Xue, W., Ge, G., et al, 2012a. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One 7 (4), e34608.
26. Liu, Z., Xu, J., Shen, X., Lv, C., Xu, T., Pei, D., 2012b. CaMKII antisense oligodeoxynucleotides protect against ischemia-induced neuronal death in the rat hippocampus. J. Neurol. Sci. 314, 104-110.
27. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
28. Malgieri, A., Kantzari, E., Patrizi, M.P., Gambardella, S., 2010. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int. J. Clin. Exp. Med. 3, 248-269.
29. Miao, Z., Luker, K.E., Summers, B.C., Berahovich, R., Bhojani, M.S., Rehemtulla, A., et al, 2007. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc. Natl. Acad. Sci. U. S. A. 104, 15735-15740.
30. Monnier, J., Boissan, M., L'Helgoualc'h, A., Lacombe, M.L., Turlin, B., Zucman-Rossi, J., et al., 2012. CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur. J. Cancer 48, 138-148.
31. Odemis, V., Lipfert, J., Kraft, R., Hajek, P., Abraham, G., Hattermann, K., et al, 2011. The presumed atypical chemokine receptor CXCR7 signals through Gi/o proteins in primary rodent astrocytes and human glioma cells. Glia 60, 372-381.
32. Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., et al, 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845-848.
33. Pulsinelli, W.A., Buchan, A.M., 1988. The four-vessel occlusion rat model: method for complete occlusion of vertebral arteries and control of collateral circulation. Stroke 19, 913-914.
34. Sánchez-Alcañiz, J.A., Haege, S., Mueller, W., Pla, R., Mackay, F., Schulz, S., et al., 2011. Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 69, 77-90.
35. Schönemeier, B., Schulz, S., Hoellt, V., Stumm, R., 2008. Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J. Neuroimmunol. 198 (1-2), 39-45.
36. Shen, L.H., Li, Y., Chen, J., Zacharek, A., Gao, Q., Kapke, A., et al, 2007. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J. Cereb. Blood Flow Metab. 27, 6-13.
37. Sierro, F., Biben, C., Martinez-Munoz, L., Mellado, M., Ransohoff, R.M., Li, M., et al, 2007. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor CXCR7. Proc. Natl. Acad. Sci. U. S. A. 104, 14759-14764.
38. Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J., et al, 2010. CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev. 29, 709-722.
39. Wang, Y., Li, G., Stanco, A., Long, J.E., Crawford, D., Potter, G.B., et al, 2011. CXCR4 and CXCR7 have distinct functions in regulating interneuron migration. Neuron 69, 61-76.
40. Wang, Y., Huang, J., Li, Y., Yang, G.Y., 2012. Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr. Drug Targets 13 (2), 166-172.
41. Wang, J., Shiozawa, Y., Wang, J., Wang, Y., Jung, Y., Pienta, K.J., et al, 2008. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J. Biol. Chem. 283, 4283-4294.
42. Wang, Y.L., Fu, W., Li, A.N., Xu, H., Liu, Z.A., Gao, D.S., 2012. Expressional changes of stromal cell-derived factor 1α and C-X-C chemokine receptor type 4 protein in the hippocampus of ischemia/reperfusion rat. Chin. J. Anat. 35, 792-795.
43. Wei, L., Fraser, J.L., Lu, Z.Y., Hu, X., Yu, S.P., 2012. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol. Dis. 46 (3), 635-645.
44. Xu, X., Zhu, F., Zhang, M., Zeng, D., Luo, D., Liu, G., et al, 2013. Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization. Cells Tissues Organs 197, 103-113.
45. Yu, L., Cecil, J., Peng, S.B., Schrementi, J., Kovacevic, S., Paul, D., et al, 2006. Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene 374, 174-179.
46. Zabel, B.A., Lewén, S., Berahovich, R.D., Jaén, J.C., Schall, T.J., 2011. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol. Cancer 10, 73.